Found: 7
Select item for more details and to access through your institution.
Correction: Identification of a novel bile marker clusterin and a public online prediction platform based on deep learning for cholangiocarcinoma.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Identification of a novel bile marker clusterin and a public online prediction platform based on deep learning for cholangiocarcinoma.
- Published in:
- BMC Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12916-023-02990-9
- By:
- Publication type:
- Article
Identification of a novel bile marker clusterin and a public online prediction platform based on deep learning for cholangiocarcinoma.
- Published in:
- BMC Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12916-023-02990-9
- By:
- Publication type:
- Article
Regular use of paracetamol and risk of liver cancer: a prospective cohort study.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-023-11767-5
- By:
- Publication type:
- Article
Establishment and characterization of a novel hilar cholangiocarcinoma cell line, CBC3T-1.
- Published in:
- Human Cell, 2024, v. 37, n. 1, p. 364, doi. 10.1007/s13577-023-01003-4
- By:
- Publication type:
- Article
Proton pump inhibitors may enhance the risk of digestive diseases by regulating intestinal microbiota.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1217306
- By:
- Publication type:
- Article
Correction: Identification of a novel bile marker clusterin and a public online prediction platform based on deep learning for cholangiocarcinoma.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice